# A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

> **NCT00302445** · PHASE4 · COMPLETED · sponsor: **Derm Research, PLLC** · enrollment: 20 (—)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Efalizumab
- **DEVICE:** Narrow Band Phototherapy

## Key facts

- **NCT ID:** NCT00302445
- **Lead sponsor:** Derm Research, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 20 (—)
- **Last updated:** 2007-07-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302445, "A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00302445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*